Detailed Information
Cited 46 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Amivantamab and lazertinib in patients with EGFR-mutant non-small cell lung (NSCLC) after progression on osimertinib and platinum-based chemotherapy: Updated results from CHRYSALIS-2.
- Authors
- Shu, CA[Shu, Catherine A.]; Goto, K[Goto, Koichi]; Ohe, Y[Ohe, Yuichiro]; Besse, B[Besse, Benjamin]; Lee, SH[Lee, Se-Hoon]; Wang, YS[Wang, Yongsheng]; Griesinger, F[Griesinger, Frank]; Yang, JCH[Yang, James Chih-Hsin]; Felip, E[Felip, Enriqueta]; Sanborn, RE[Sanborn, Rachel E.]; Caro, RB[Caro, Reyes Bernabe]; Curtin, JC[Curtin, Joshua C.]; Chen, J[Chen, Jun]; Mahoney, JM[Mahoney, Janine M.]; Trani, L[Trani, Leonardo]; Bauml, JM[Bauml, Joshua Michael]; Knoblauch, RE[Knoblauch, Roland Elmar]; Thayu, M[Thayu, Meena]; Cho, BC[Cho, Byoung Chul]
- Issue Date
- 1-Jun-2022
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.40, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 40
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.